Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Technology
  • Industry: Semiconductors
  • Sub-Industry: Semiconductor Mfg

CLRX:US

0.9501 USD 0.0498 4.98%

As of 11:36:36 ET on 04/21/2015.

Snapshot for CollabRx Inc (CLRX)

Open: 0.9615 Day's Range: 0.9400 - 0.9796 Volume: 154,961
Previous Close: 0.9999 52wk Range: 0.5100 - 3.2700 1-Yr Rtn: -70.94%

Stock Chart for CLRX

No chart data available.
  • CLRX:US 0.9501
  • 1D
  • 1M
  • 1Y
0.9999
Interactive CLRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CLRX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -1.8300
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 9.46
Shares Outstanding (M) 9.95
30 Day Average Volume 459,627
Price/Book (mrq) 2.1902
Price/Sale (ttm) 5.7829
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CLRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CLRX

CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care.

Thomas R Mika "Tom"Chairman/Pres/CEO/Acting CFOSmruti J VidwansChief Science Officer
Clifford BaronVP/COOGavin GordonVP:Bus Dev & Strategic Alliances
More Company Profile & Key Executives for CLRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil